Document is current

Article History

Received: 15 July 2024

Accepted: 28 November 2024

First Online: 6 February 2025

Declarations

:

: S.F.is supported by the Deutsche Forschungsgemeinschaft (DFG). He has received consultancy and lecture fees as well as support/ travel grants for meetings from Abbot, Abiomed, Amarin, Amgen, AstraZeneca, Bayer, Berlin-Chemie, Biotronik, Boehringer, Bristol-Myers Squibb, Boehringer, Daiichi Sankyo, Edwards, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Siemens, Tomtec, Vifor, Zoll. S.S.is supported by the CHFC Würzburg, and by the German Federal Ministry of Education and Research (BMBF). He has received consultancy and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, and Servier. C.M.reports research cooperation with the University of Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, German Germany (MED-1811–0011, LSM-2104–0002, and LSM-2403-0005); she is supported by the German Research Foundation (DFG) within the Comprehensive Research Center 1525 'Cardio-immune interfaces’ (453989101, project C5) and receives financial support from the Interdisciplinary Center for Clinical Research—IZKF Würzburg (advanced clinician-scientist program; AdvCSP 3). She further received advisory and speakers honoraria as well as travel grants from Tomtec, Edwards, Alnylam, Pfizer, Boehringer Ingelheim, Eli Lilly, SOBI, AstraZeneca, NovoNordisk, Alexion, Janssen, Bayer, Intellia, and EBR Systems; she serves as principal investigator in trials sponsored by Alnylam, Bayer, NovoNordisk, Intellia and AstraZeneca. J.N.has no conflicts of interest regarding the present work. G.G.has no conflicts of interest regarding the present work. F.S.has no conflicts of interest regarding the present work. V.C.has no conflicts of interest regarding the present work. D.P.has no conflicts of interest regarding the present work. L.S.has no conflicts of interest regarding the present work. M.C.has no conflicts of interest regarding the present work. N.H.has no conflicts of interest regarding the present work. M.S.has no conflicts of interest regarding the present work. P.H. has no conflicts of interest regarding the present work.

: The protocol and procedures of the STAAB cohort study are in accordance with the Declaration of Helsinki and have been approved by the Ethics Committee of the Medical Faculty (vote #98/13) and the Data Protection Officer of the University of Würzburg. All participants gave written informed consent prior to any study examination.